Your search returned 4 results.

Results
	1.	CYP2C8 and CYP3A4 are the principal enzymes involved in the human in vitro biotransformation of the insulin secretagogue repaglinide. [electronic resource] by Bidstrup, Tanja Busk Bjørnsdottir, Inga Sidelmann, Ulla Grove Thomsen, Mikael Søndergård Hansen, Kristian Tage Producer: 20040206 In: British journal of clinical pharmacology vol. 56 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	2.	The impact of CYP2C8 polymorphism and grapefruit juice on the pharmacokinetics of repaglinide. [electronic resource] by Bidstrup, Tanja Busk Damkier, Per Olsen, Anette Kristensen Ekblom, Marianne Karlsson, Anders Brøsen, Kim Producer: 20060613 In: British journal of clinical pharmacology vol. 61 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	3.	Rifampicin seems to act as both an inducer and an inhibitor of the metabolism of repaglinide. [electronic resource] by Bidstrup, Tanja Busk Stilling, Nicolaj Damkier, Per Scharling, Birgitte Thomsen, Mikael Søndergård Brøsen, Kim Producer: 20040929 In: European journal of clinical pharmacology vol. 60 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	4.	The relative bioavailability of loratadine administered as a chewing gum formulation in healthy volunteers. [electronic resource] by Noehr-Jensen, Lene Damkier, Per Bidstrup, Tanja Busk Pedersen, Rasmus Steen Nielsen, Flemming Brosen, Kim Producer: 20070131 In: European journal of clinical pharmacology vol. 62 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)